Login / Signup

Hypertriglyceridemia-induced acute necrotizing pancreatitis: Poor clinical outcomes requiring revisiting management modalities.

Yazan AbboudMeet ShahBenjamin SimmonsKranthi MandavaJohn E M MoralesFouad JaberSaqer AlsakarnehMohamed IsmailKaveh Hajifathalian
Published in: JGH open : an open access journal of gastroenterology and hepatology (2024)
Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is the third most common cause of AP after gallstones and alcohol. Supportive measures, intravenous insulin, and plasmapheresis are possible treatment modalities for HTG-AP; however, definitive guidelines evaluating the best therapeutic approach are not clearly established. We present a rare case of a 42-year-old male without known comorbidities who was found to have HTG-AP. Despite early initiation of intravenous insulin and plasmapheresis and the initial decline in his triglycerides level, his condition was complicated by necrotizing pancreatitis and subsequent multi-organ failure. Future studies are warranted to evaluate the role of plasmapheresis in HTG-AP and its efficacy.
Keyphrases
  • transcription factor
  • rare case
  • type diabetes
  • high dose
  • glycemic control
  • metabolic syndrome
  • low dose
  • insulin resistance
  • rectal cancer
  • weight loss
  • drug induced
  • combination therapy
  • smoking cessation